enVVeno Medical Corporation (NVNO) Earnings History
Net Loss12 years of earnings data (2014–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
enVVeno Medical Corporation (NVNO) Earnings Overview
As of June 28, 2026, enVVeno Medical Corporation (NVNO) reported trailing twelve-month net income of -$19M, reflecting +97.9% year-over-year growth. The company earned $-28.77 per diluted share over the past four quarters.
Looking at the long-term picture, NVNO's historical earnings data spans multiple years. The company achieved its highest annual net income of -$1M in fiscal 2014.
enVVeno Medical Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including VNRX (-$25M net income, -1352.2% margin), TELA (-$40M net income, -48.4% margin), NVCR (-$173M net income, -20.8% margin), NVNO has comparable earnings metrics. Compare NVNO vs VNRX →
NVNO Earnings vs Peers
Earnings metrics vs comparable public companies
NVNO Historical Earnings Data (2014–2025)
12 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$19M | +10.8% | -$21M | $-33.06 | - | - |
| 2024 | -$22M | +7.2% | -$24M | $-1555.75 | - | - |
| 2023 | -$24M | +4.7% | -$25M | $-2339.75 | - | - |
| 2022 | -$25M | -49.3% | -$25M | $-2695.00 | - | - |
| 2021 | -$17M | -80.9% | -$17M | $-2327.50 | - | - |
| 2020 | -$9M | -19.8% | -$9M | $-9236.50 | - | - |
| 2019 | -$8M | +41.5% | -$8M | $-14822.50 | -24406.7% | -24566.5% |
| 2018 | -$13M | -67.4% | -$8M | $-53495.75 | -6991.5% | -4210.5% |
| 2017 | -$8M | -32.4% | -$6M | $-26068.00 | -1845.8% | -1445.9% |
| 2016 | -$6M | -267.0% | -$5M | $-10412.50 | -749.0% | -592.8% |
| 2015 | -$2M | -14.7% | -$1M | $-4483.50 | - | - |
| 2014 | -$1M | - | $-952,659 | $-5194.00 | -591.1% | -402.8% |
Download Data
Export NVNO earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
12+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
NVNO — Frequently Asked Questions
Quick answers to the most common questions about buying NVNO stock.
What is NVNO earnings per share (EPS)?
NVNO trailing twelve-month (TTM) diluted EPS is $-28.77, reflecting +97.9% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2014 to 2025 is available in the table on this page.
What is enVVeno Medical Corporation's net income?
enVVeno Medical Corporation (NVNO) trailing twelve-month net income is $-19M as of 2025. Earnings grew +97.9% year-over-year.
Is NVNO profitable?
NVNO is not currently profitable on a TTM basis, reporting a net loss of $-19M. Net margin is N/A. Investors should monitor for a return to profitability.
What is NVNO's earnings growth rate?
NVNO compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2014 to 2025.
What are NVNO's profit margins?
enVVeno Medical Corporation net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -56.2%.
Is NVNO growing earnings?
Yes, NVNO earnings are accelerating — EPS growth of +97.9% exceeds the 5-year CAGR of N/A. TTM net income reached $-19M. Earnings momentum is strengthening.
What was NVNO's best earnings year?
enVVeno Medical Corporation's highest annual net income on record is $-1M, achieved in fiscal year 2014. Earnings history on this page spans 2014 to 2025 and includes all annual and quarterly figures.
What were NVNO's earnings last quarter?
NVNO's most recent reported quarter was Q1 2026. Net income was $-4M with diluted EPS of $-5.89. For a full breakdown of all quarters, see the quarterly earnings table on this page.